Our Mission
Trinity Biotech is dedicated to being your partner of choice by providing quality products and the highest level of service in its chosen diagnostics segments. Through innovation and total commitment we strive to create value for our people, our customers and our shareholders.
LATEST NEWS
Trinity Announce First Quarter 2009 Results
Trinity to Announce First Qtr 2009 Results
Commencement of TriStat CLIA Trials
TRIB Announce First 3 Destiny Max Placements in UK
Trinity Files 510k for Destiny Max with FDA
Trinity Announce launch of Destiny Max into Europe
Trinity Announce Cost Reduction Measures
Trinity Biotech Announce First Destiny Max Orders
Trinity Biotech plc is a public company, specialising in the
development, manufacture and marketing of clinical diagnostic
products.
Our Vision
Trinity Biotech will establish positions of leadership in its chosen
diagnostics segments through a combination of R&D, acquisitions and strategic investments.